Trial intelligence / Profile preview

DHEA and Exercise for Sarcopenia and Osteopenia of Aging

NCT00205686Phase 3Completed

Sponsor
Washington University School of Medicine
Start
Apr 2001
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 3 trial of dehydroepiandrosterone in Sarcopenia, osteopenia, sponsored by Washington University School of Medicine. Started Apr 2001; status: completed.

02

Drugs

dehydroepiandrosterone
03

Conditions

Sarcopeniaosteopenia

Beyond the preview

Go deeper on NCT00205686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00205686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call